Ophthalmic Statistics Note 4: analysing data from randomised controlled trials with baseline and follow-up measurements

Br J Ophthalmol. 2014 Nov;98(11):1467-9. doi: 10.1136/bjophthalmol-2014-305614. Epub 2014 Aug 7.
No abstract available

Keywords: Neovascularisation.

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Bevacizumab
  • Data Interpretation, Statistical*
  • Follow-Up Studies
  • Humans
  • Macular Degeneration / drug therapy*
  • Macular Degeneration / physiopathology
  • Randomized Controlled Trials as Topic / methods*
  • Ranibizumab
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / drug effects*
  • Visual Acuity / physiology

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Ranibizumab